• Shopping Cart
    There are no items in your cart

CLSI EP23 A : 1ED 2011

Superseded

Superseded

A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.

View Superseded by

LABORATORY QUALITY CONTROL BASED ON RISK MANAGEMENT

Available format(s)

Hardcopy , PDF

Language(s)

English

Published date

25-10-2011

Superseded date

19-08-2023

Superseded by

CLSI EP23:2023

€394.93
Excluding VAT

Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Quality Control Toolbox
6 Information Gathering for Risk Assessment
7 Developing the Quality Control Plan
8 Postimplementation Monitoring of the
  Quality Control Plan
References
Appendix A - Quick Guide Checklist for Establishing a
             Quality Control Plan Based on Risk Management
Appendix B - The Laboratory Risk Assessment: Example
             Glucose Measurement Using an Automated
             Measuring System
Appendix C - Summary of Laboratory Risk Assessment Table -
             Example: Glucose Measurement on an Automated
             Measuring System
Appendix D - The Quality Control Plan Developed From the
             Individual Components of the Quality Control
             Strategies From Appendixes B and C - Example:
             Glucose Measurement on an Automated Measuring
             System
Appendix E - Example of Failure Investigation and Corrective
             Action for Glucose Measurement on an Automated
             Measuring System
The Quality Management System Approach
Related CLSI Reference Materials

Specifies guidance based on risk management for laboratories to develop quality control plans tailored to the particular combination of measuring system, laboratory setting, and clinical application of the test.

DevelopmentNote
Supersedes CLSI EP23 P. (11/2011)
DocumentType
Miscellaneous Product
ISBN
1-56238-767-7
Pages
84
PublisherName
Clinical Laboratory Standards Institute
Status
Superseded
SupersededBy

CLSI C49:2018(R2023) Analysis of Body Fluids in Clinical Chemistry
CLSI M52:2010(R2020) Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems
CLSI EP39 ED1:2021 A Hierarchical Approach to Selecting Surrogate Samples for the Evaluation of In Vitro Medical Laboratory Tests

CLSI M29 A3 : 3ED 2005 ACQUIRED INFECTIONS; APPROVED GUIDELINE
CLSI GP2 A5 : 5ED 2006 LABORATORY DOCUMENTS - DEVELOPMENT AND CONTROL

€394.93
Excluding VAT